Keryx Biopharmaceuticals, Inc. 6,900,000 Shares Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • January 28th, 2014 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Keryx Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (collectively, the “Underwriters”) for whom J.P. Morgan Securities LLC is acting as representative (the “Representative”), an aggregate of 6,900,000 shares (the “Underwritten Shares”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”) and, at the option of the Underwriters, up to an additional 1,035,000 shares of Common Stock (the “Option Shares” and, together with the Underwritten Shares, the “Shares”).
